Innovent Biologics
Suzhou, Jiangsu, China · Biotechnology, Health Care, Manufacturing
Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for the treatment of major diseases such as cancer. On 31 October, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK. Since its inception, Innovent has developed a fully-integrated multi-functional platfo
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Suzhou, Jiangsu, China
- Employees
- 5,700
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (IVBXF)
- Website
- www.innoventbio.com
- Company page
Recent activity at Innovent Biologics
About Innovent Biologics: questions and answers
What does Innovent Biologics do?
Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for the treatment of major diseases such as cancer. On 31 October, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK. Since its inception, Innovent has developed a fully-integrated multi-functional platfo
Where is Innovent Biologics headquartered?
Innovent Biologics is headquartered in Suzhou, Jiangsu, China.
How many employees does Innovent Biologics have?
Innovent Biologics has about 5,700 employees.
What is the latest news on Innovent Biologics?
On May 29, 2026, Innovent Biologics partners with Pfizer to develop oncology medicines worth up to $10.5 billion.
Is Innovent Biologics a public company?
Yes. Innovent Biologics is publicly traded under the ticker IVBXF.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy